News FDA drops PreCert report, new digital health guidances The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digit
Views & Analysis Digital health round-up: the health-tech convergence puzzle How many pieces are left of the puzzle?
News Neurogene falls again on Rett gene therapy side effects Neurogene has halted patient enrolment in the high-dose arm of its trial of Rett syndrome gene therapy, sparking another run on its shares.
Digital Sponsored Decoding physician prescribing behaviour: A data-driven jour... Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge.
